Stay updated on Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial

Sign up to get notified when there's something new on the Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page history now lists Revision: v3.6.3, replacing the previous v3.6.2.
    Difference
    0.1%
    Check dated 2026-07-03T23:54:47.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A new revision entry (v3.6.2) was added to the study record history, following the previous v3.6.0 entry. This documents an incremental update to the record on the ClinicalTrials.gov page.
    Difference
    0.1%
    Check dated 2026-06-26T19:53:31.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    New entries appear in the study record history: 'Check who can join' and 'Find Contact Information', and the page revision now shows v3.6.0 (with v3.5.5 removed).
    Difference
    0.3%
    Check dated 2026-06-12T12:50:46.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The study history now shows a new revision entry (v3.5.5) as the latest update, replacing the previous revision (v3.5.4) in the list.
    Difference
    0.1%
    Check dated 2026-06-05T09:58:01.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The record history now shows a new latest revision entry labeled v3.5.4. This replaces the previous v3.5.3 and indicates a minor update to the page’s revision history for this study.
    Difference
    0.1%
    Check dated 2026-05-14T23:11:24.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Revision: v3.5.3 is now displayed, replacing the previous v3.5.2. This indicates a new site release of ClinicalTrials.gov.
    Difference
    0.1%
    Check dated 2026-04-30T15:38:41.000Z thumbnail image

Stay in the know with updates to Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial page.